β-Catenin-driven adrenocortical carcinoma is characterized with immune exclusion.

about

β-Catenin-driven adrenocortical carcinoma is characterized with immune exclusion.

Item

http://www.wikidata.org/entity/Q55312964

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

β-Catenin-driven adrenocortical carcinoma is characterized with immune exclusion.

@en

β-Catenin-driven adrenocortical carcinoma is characterized with immune exclusion.

@nl

type

Item

label

β-Catenin-driven adrenocortical carcinoma is characterized with immune exclusion.

@en

β-Catenin-driven adrenocortical carcinoma is characterized with immune exclusion.

@nl

prefLabel

β-Catenin-driven adrenocortical carcinoma is characterized with immune exclusion.

@en

β-Catenin-driven adrenocortical carcinoma is characterized with immune exclusion.

@nl

P1476

β-Catenin-driven adrenocortical carcinoma is characterized with immune exclusion.

@en

P2093

Chenchen Feng

http://www.w3.org/2001/XMLSchema#string

Guanxiong Ding

http://www.w3.org/2001/XMLSchema#string

Shenghua Liu

http://www.w3.org/2001/XMLSchema#string

Zhongwen Zhou

http://www.w3.org/2001/XMLSchema#string

P2860

COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer

Lack of beta-catenin affects mouse development at gastrulation

Balancing cell adhesion and Wnt signaling, the key role of beta-catenin

N-cadherin in adult rat cardiomyocytes in culture. II. Spatio-temporal appearance of proteins involved in cell-cell contact and communication. Formation of two distinct N-cadherin/catenin complexes

Programmed death ligand-1 expression in adrenocortical carcinoma: an exploratory biomarker study.

CD11c-Expressing B Cells Are Located at the T Cell/B Cell Border in Spleen and Are Potent APCs

Cancer immunotherapy targeting neoantigens.

Comprehensive analyses of tumor immunity: implications for cancer immunotherapy.

Molecular markers and targeted therapies for adrenocortical carcinoma.

B cell regulation in cancer and anti-tumor immunity.

P304

2029-2036

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/OTT.S159979

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-04-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29670378

http://www.w3.org/2001/XMLSchema#string

P932

5898592

http://www.w3.org/2001/XMLSchema#string